Chemotherapy can profoundly affect patients' quality of life (QOL), yet few clinical trials in advanced cervical cancer have included QOL outcomes. Our purpose was to assess the impact of cisplatin (C) versus cisplatin plus paclitaxel (CP) on overall QOL and pain in cervical cancer patients.
Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
Psychosocial Oncology, Comprehensive Cancer Center of Wake Forest University, Department of Internal Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1082, USA. rmcquell@wfubmc.edu
